Back to search

TAMOXIFEN AND THE UTERUS AND ENDOMETRIUM

Data up to Jan 2025

Published1989
Citations252
References13

Total Citations Per Year

Abstract

References (13)

Revised American Fertility Society Classification of Endometriosis: 1985

1985 • 1,790 citations

Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast Cancer

1988 • 921 citations

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women

1988 • 631 citations

Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse.

1988 • 420 citations

Endometrial adenocarcinoma in breast cancer patients receiving antiestrogens.

1985 • 224 citations

ADJUVANT TAMOXIFEN IN THE MANAGEMENT OF OPERABLE BREAST CANCER: THE SCOTTISH TRIAL

1987 • 145 citations

Estrogen-Like Action of Tamoxifen on Vaginal Epithelium in Breast Cancer Patients

1981 • 138 citations

Tamoxifen as a possible chemotherapeutic agent in endometrial adenocarcinoma

1981 • 64 citations

Clinical aspects and development of antioestrogen therapy: a review of the endocrine effects of tamoxifen in animals and man.

1981 • 61 citations

Endometriosis developing during tamoxifen therapy

1988 • 45 citations

Effects of tamoxifen, medroxyprogesterone acetate, and their combination on human endometrial estrogen and progestin receptor concentrations, 17β-hydroxysteroid dehydrogenase activity, and serum hormone concentrations

1982 • 33 citations

Preliminary report on the use of tamoxifen in the treatment of endometriosis

1987 • 22 citations

Control of Steroid Receptor Levels and Steroid Antagonism

1979 • 21 citations

Cited By (0)

No citing papers found in database

TAMOXIFEN AND THE UTERUS AND ENDOMETRIUM (1989) – The Lancet | Metascience Observatory Explorer